Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2008-09-01 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LA GACILLY (56200), Morbihan
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMARCIE GACILIENNE : revenue, balance sheet and financial ratios
PHARMARCIE GACILIENNE is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LA GACILLY (56200),
this company of category PME
shows in 2022 a revenue of 3.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMARCIE GACILIENNE (SIREN 508357076)
Indicator
2023
2022
2019
2018
2017
2016
Revenue
N/C
3 362 866 €
N/C
N/C
N/C
N/C
Net income
204 492 €
278 955 €
204 010 €
205 260 €
227 348 €
204 431 €
EBITDA
N/C
371 154 €
N/C
N/C
N/C
N/C
Net margin
N/C
8.3%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMARCIE GACILIENNE generates positive net income of 204 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 204 k€ -> 204 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
204 492 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 10%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 79%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
10.173%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
79.23%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2022
2023
Debt ratio
122.436
91.44
64.958
43.785
8.772
10.173
Financial autonomy
41.278
47.184
54.998
63.797
82.489
79.23
Repayment capacity
None
None
None
None
0.72
None
Cash flow / Revenue
None%
None%
None%
None%
8.26%
None%
Sector positioning
Debt ratio
10.172023
2019
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent
In 2023, the debt ratio of PHARMARCIE GACILIENNE (10.17) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
79.23%2023
2019
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent
In 2023, the financial autonomy of PHARMARCIE GACILIENNE (79.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.72 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMARCIE GACILIENNE (0.72) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 145.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2022
2023
Liquidity ratio
266.924
252.298
246.588
247.79
160.547
145.323
Interest coverage
None
None
None
None
0.043
None
Sector positioning
Liquidity ratio
145.322023
2019
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Average-45 pts over 3 years
In 2023, the liquidity ratio of PHARMARCIE GACILIENNE (145.32) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
0.04x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMARCIE GACILIENNE (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMARCIE GACILIENNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2022
2023
Operating WCR
0 €
0 €
0 €
0 €
106 737 €
0 €
Inventory turnover (days)
0
0
0
0
14
0
Customer payment term (days)
0
0
0
0
1
0
Supplier payment term (days)
0
0
0
0
33
0
Positioning of PHARMARCIE GACILIENNE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMARCIE GACILIENNE is estimated at
2 412 898 €
(range 1 467 399€ - 3 391 993€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1467k€2412k€3391k€
2 412 898 €Range: 1 467 399€ - 3 391 993€
NAF 5 année 2023
Valuation method used
Net Income Multiple
204 492 €
×
11.8x
=2 412 898 €
Range: 1 467 399€ - 3 391 994€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMARCIE GACILIENNE with other companies in the same sector:
Frequently asked questions about PHARMARCIE GACILIENNE
What is the revenue of PHARMARCIE GACILIENNE ?
The revenue of PHARMARCIE GACILIENNE in 2022 is 3.4 M€.
Is PHARMARCIE GACILIENNE profitable?
Yes, PHARMARCIE GACILIENNE generated a net profit of 204 k€ in 2023.
Where is the headquarters of PHARMARCIE GACILIENNE ?
The headquarters of PHARMARCIE GACILIENNE is located in LA GACILLY (56200), in the department Morbihan.
Where to find the tax return of PHARMARCIE GACILIENNE ?
The tax return of PHARMARCIE GACILIENNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMARCIE GACILIENNE operate?
PHARMARCIE GACILIENNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart